Liquid Biopsy News and reporting on cell-free DNA testing. IV BioHoldings Partners With P4 Diagnostix, Unveils 'Bio Innovation Studio' The partnership with lab partner P4 Diagnostix aims to fast-track liquid biopsy diagnostic tests across pulmonary, metabolic, and women's health diseases. Data Demonstrates Lucence Liquid Biopsy Test Can Track Treatment-Based ctDNA Changes Premium Researchers used the amplicon-based LiquidHallmark test to correlate tumor DNA changes with treatment response. Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy Leaders from collaborating Cleveland Clinic institutes will work with PGDx to optimize its ctDNA test reporting and adapt its technology for new oncology applications. OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response Premium In data presented at the ESMO Congress, a signature of eight proteins and two clinical parameters appeared to differentiate responders and non-responders. MD Anderson Researchers Explore Neoadjuvant Keytruda in MSI-high Solid Tumors The study presented at the ESMO Congress also suggested that ctDNA testing may predict which patients should have surgery to remove their tumors and those who can do without it. Sep 19, 2021 ESMO Data in HER2-Positive Lung, Breast Cancer Bolster Daiichi Sankyo, AstraZeneca's Enhertu Premium Sep 14, 2021 Exact Sciences, NSABP Validating Ability of ctDNA Test to Detect MRD in Colorectal Cancer Patients Sep 8, 2021 Natera Signatera Test to be Used in Study of MRD-Guided Treatment for Colon Cancer Patients Sep 2, 2021 MD Anderson Study Further Supports Using Liquid Biopsy First to Gauge EGFR Mutations in Lung Cancer Premium Sep 2, 2021 AnPac Bio Developing Multi-Cancer Testing Device Based on Biophysical Properties of Blood Components Premium Aug 31, 2021 Cell-Free DNA Can Help Predict Pathological Complete Response, Gauge Minimal Residual Disease Aug 31, 2021 Blood Testing Distinguishes Benign Tumors From Precancerous Condition Aug 31, 2021 Oxford BioDynamics Awarded Grant to Apply EpiSwitch to ICI Cancer Therapy Response Aug 27, 2021 NGS Use for Breast Cancer Increases Sixfold in Community Oncology Clinics, Study Finds Premium Aug 23, 2021 AnPac Bio Files Multi-Cancer Detection Device for Registrational Testing With China's NMPA Aug 18, 2021 Illumina Acquires Grail Despite Ongoing Regulatory Scrutiny Aug 18, 2021 Datar Cancer Genetics Expands Business from Treatment Monitoring to Dx and Screening Premium Aug 5, 2021 Preferred Medicine Building Data for Breast Cancer MicroRNA Screening Test Premium Jul 29, 2021 Genetron Health Partners with Guizhou Local Government for Liver Cancer Early Screening Project Jul 26, 2021 Foresight Diagnostics Commercializing PhasED-seq Liquid Biopsy Tech for Improved MRD Detection Premium Jul 22, 2021 Natera Minimal Residual Disease Test Predicts Oligometastatic CRC Patient Outcomes in New Study Premium Jul 20, 2021 UK Group Validating Natera ctDNA Test to Guide Therapy for Post-Operative Bladder Cancer Premium Jul 20, 2021 Micronoma, University of New South Wales to Develop Liver Cancer Dx Using $4M Grant Jul 16, 2021 FDA Approves Foundation Medicine's Liquid Biopsy Test as CDx for Novartis' Tabrecta in NSCLC Jul 2, 2021 Elicio Therapeutics Begins Phase I/II Trial of Vaccine Against KRAS-Driven Tumors Load More Breaking News Global Coalition for Adaptive Research Launches Adaptive Platform Trial for Ovarian Cancer In Brief This Week: Carisma Therapeutics, Proteomedix, American Cancer Society Lion TCR to Begin Phase Ib/II Trial of Autologous Liver Cancer T-Cell Receptor Therapy Novartis's Advanced Accelerator Applications Licenses Theragnostics' Gallium-68 Platform European Society for Medical Oncology Congress 2021: Precision Oncology Data Roundup Rain Therapeutics' Milademetan Shows Clinical Activity in MDM2-Amplified Intimal Sarcoma What's Popular? In Liquid Biopsy ESMO Data in HER2-Positive Lung, Breast Cancer Bolster Daiichi Sankyo, AstraZeneca's Enhertu Premium MD Anderson Researchers Explore Neoadjuvant Keytruda in MSI-high Solid Tumors Data Demonstrates Lucence Liquid Biopsy Test Can Track Treatment-Based ctDNA Changes Premium Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy IV BioHoldings Partners With P4 Diagnostix, Unveils 'Bio Innovation Studio'